BACKGROUND: Immature dendritic cells (imDC) can prolong allograft survival in murine transplantation models. Recent data indicate that semi-mature or alternatively activated DC (aaDC) may be even more tolerogenic. METHODS: We compared the phenotype and regulatory capacity of: a) imDC, cultured in the presence of dexamethasone (DEX), b) mature DC (matDC), activated with LPS, and c) aaDC, activated with LPS after pretreatment with DEX. RESULTS: As compared to imDC, aaDCs displayed a slight upregulation of CD40 while expression levels of MHC-II and CD86 remained low. The production of proinflammatory cytokines, in particular IL-12, by aaDC was much lower than by matDC while both produced similar amounts of the regulatory cytokine IL-10 leading to an increased IL-10/IL-12 ratio for aaDC. After infusion of donor type aaDCs, responder cells isolated from the recipient mice showed donor-specific hyporesponsiveness to restimulation by matDC. Infusion of matDC was immunogenic, while imDC induced partial hyporesponsiveness. Importantly, pretreatment with donor type aaDC (but not imDC) resulted in prolonged survival of a completely MHC-mismatched heart allograft. CONCLUSIONS: Alternatively activated DC are more efficacious than the classical imDC in the regulation of the alloimmune response, which may be related to a distinct cytokine profile characterized by an increased IL-10/IL12 ratio.
BACKGROUND: Immature dendritic cells (imDC) can prolong allograft survival in murine transplantation models. Recent data indicate that semi-mature or alternatively activated DC (aaDC) may be even more tolerogenic. METHODS: We compared the phenotype and regulatory capacity of: a) imDC, cultured in the presence of dexamethasone (DEX), b) mature DC (matDC), activated with LPS, and c) aaDC, activated with LPS after pretreatment with DEX. RESULTS: As compared to imDC, aaDCs displayed a slight upregulation of CD40 while expression levels of MHC-II and CD86 remained low. The production of proinflammatory cytokines, in particular IL-12, by aaDC was much lower than by matDC while both produced similar amounts of the regulatory cytokine IL-10 leading to an increased IL-10/IL-12 ratio for aaDC. After infusion of donor type aaDCs, responder cells isolated from the recipient mice showed donor-specific hyporesponsiveness to restimulation by matDC. Infusion of matDC was immunogenic, while imDC induced partial hyporesponsiveness. Importantly, pretreatment with donor type aaDC (but not imDC) resulted in prolonged survival of a completely MHC-mismatched heart allograft. CONCLUSIONS: Alternatively activated DC are more efficacious than the classical imDC in the regulation of the alloimmune response, which may be related to a distinct cytokine profile characterized by an increased IL-10/IL12 ratio.
Authors: Sherrie J Divito; Zhiliang Wang; William J Shufesky; Quan Liu; Olga A Tkacheva; Angela Montecalvo; Geza Erdos; Adriana T Larregina; Adrian E Morelli Journal: Blood Date: 2010-06-24 Impact factor: 22.113
Authors: Rodolfo Thomé; Luidy K Issayama; Thiago Alves da Costa; Rosária D Gangi; Isadora T Ferreira; Catarina Rapôso; Stefanie C P Lopes; Maria Alice da Cruz Höfling; Fábio T M Costa; Liana Verinaud Journal: Immunology Date: 2014-10 Impact factor: 7.397
Authors: Z Wang; S J Divito; W J Shufesky; T Sumpter; H Wang; O A Tkacheva; W Wang; C Liu; A T Larregina; A E Morelli Journal: Am J Transplant Date: 2012-04-14 Impact factor: 8.086
Authors: Brenda M Bosma; Herold J Metselaar; Nicole M A Nagtzaam; Roel de Haan; Shanta Mancham; Luc J W van der Laan; Ernst J Kuipers; Jaap Kwekkeboom Journal: Immunology Date: 2008-02-27 Impact factor: 7.397
Authors: Amy E Anderson; David J Swan; Bethan L Sayers; Rachel A Harry; Angela M Patterson; Alexei von Delwig; John H Robinson; John D Isaacs; Catharien M U Hilkens Journal: J Leukoc Biol Date: 2008-11-06 Impact factor: 4.962